Nadine Wentzell

  • Since September 2014 Research Fellow at Leibniz Institute für Prevention Research and Epidemiology - BIPS
  • May 2014 – September 2014 Research Fellow at Hamburg University of Applied Sciences
  • March 2014 – September 2014 Temporary Lecturer at Hamburg University of Applied Sciences
  • March 2014 Master of Science in Health Sciences, Hamburg University of Applied Sciences (Master Thesis: Exploratory Analysis of Biologicals in the Drug Treatment of Patients with Crohn's Disease using Administrative Claims Data)
  • September 2011 Bachelor of Arts in Public Health Political Sciences, University of Bremen

  • Drug Utilization and Drug Safety, especially during pregnancy
  • Biologicals

    Selected BIPS-Publications

  • Articles with peer review

  • Wentzell N, Haug U. Characterization of pregnancies among women with epilepsy using valproate before or during pregnancy - A longitudinal claims data analysis from Germany. Epilepsy Research. 2022;179:106838.
    https://doi.org/10.1016/j.eplepsyres.2021.106838
    https://repository.publisso.de/resource/frl:6431122
  • Schäfer W, Wentzell N, Schink T, Haug U. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis. Reproductive Toxicology. 2021;102:90-97.
    https://doi.org/10.1016/j.reprotox.2021.04.005
    https://repository.publisso.de/resource/frl%3A6428346
  • Schink T, Wentzell N, Dathe K, Onken M, Haug U. Estimating the beginning of pregnancy in German claims data: Development of an algorithm with a focus on the expected delivery date. Frontiers in Public Health. 2020;8:350.
    https://doi.org/10.3389/fpubh.2020.00350
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchung zeitlicher Trends basierend auf Versichertendaten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2018;61(8):1022-1029.
    https://doi.org/10.1007/s00103-018-2768-1
  • Wentzell N, Schink T, Haug U, Ulrich S, Niemeyer M, Mikolajczyk R. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data. Pharmacoepidemiology and Drug Safety. 2018;27(9):1005-1010.
    https://doi.org/10.1002/pds.4588
    https://repository.publisso.de/resource/frl%3A6417552

  • Articles without peer review

  • Schink T, Wentzell N, Haug U. Arzneimittel in der Schwangerschaft - Potenzial von Sekundärdaten. Public Health Forum. 2017;25(3):221-223.
    https://doi.org/10.1515/pubhef-2017-0026

  • Book chapters

  • Fröhlich N, Schink T. Aclidinium- oder Tiotropiumbromid? Untersuchung von Prädiktoren einer Aclidiniumbromidneuverordnung auf Basis von Routinedaten der DAK-Gesundheit. In: Rebscher H, editors. AMNOG-Report 2016. Nutzenbewertung von Arzneimitteln in Deutschland. Heidelberg: medhochzwei. 2016. S. 223-236.

  • Presentations at scientific meetings/conferences

  • Schink T, Wentzell N, Dathe K, Onken M, Haug U. Fetotoxicity of RAAS-inhibitors. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online presentation. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3705)
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Valproatverordnungen bei Mädchen und Frauen im gebärfähigen Alter in Deutschland: Untersuchungen zeitlicher Trends basierend auf Versicherungsdaten. 13. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26.-28. September 2018, Bremen.
  • Wentzell N, Kollhorst B, Schink T. Predictors for the prescription of aclidinium bromide as compared to tiotropium bromide using German claims data. Congress "Health - Exploring Complexity: An Interdisciplinary Systems Approach (HEC2016)." Joint Annual Meeting of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS), the German Society for Epidemiology (DGEpi), the International Epidemiological Association - European Region (IEA-EEF) and the European Federation for Medical Informatics Association (EFMI), 28 August-2 September 2016, Munich. (Abstract published in: European Journal of Epidemiology. 2016;31(Suppl.1):S227)
  • Wentzell N, Schink T. Indikatoren zur Abbildbarkeit von Schwangerschaftsverläufen in deutschen Krankenkassendaten am Beispiel der deutschen pharmakoepidemiologischen Forschungsdatenbank (GePaRD). Methodenworkshop der Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten (AGENS), 3.-4. März 2016, München.
  • Fröhlich N, Timmer A, Zöllner Y. Explorative Analyse von Biologika in der medikamentösen Versorgung von Patienten mit Morbus Crohn auf Basis von Krankenkassendaten. Forschungstag des Competence Centers Gesundheit, 10. Juni 2014, Hamburg.
  • Fröhlich N, Albers HM, Timmer A. Machbarkeitsstudie zur Verwendung von Krankenkassendaten im Rahmen der Versorgungsforschung am Beispiel chronisch entzündlicher Darmerkrankungen (CED). 58. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (DGMS), 1.-5. September 2013, Lübeck.

  • Posters at scientific meetings/conferences

  • Schäfer W, Wentzell N, Haug U. St. John's Wort: Utilization during pregnancy and pregnancy outcomes. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3719)
  • Wentzell N, Schink T, Witzleb AJ, Haug U. Utilization patterns of valproate in women with epilepsy before and during pregnancy. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3844)
  • Witzleb AJ, Wentzell N, Schink T, Haug U. Exploratory analyses of modafinil utilization during pregnancy and diagnoses of malformations in the offspring. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):3704)
  • Wentzell N, Haug U, Dathe K, Onken M, Schink T. Information on the expected delivery date in German claims data: Assessing its potential to estimate the beginning of pregnancy. 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 22-26 August 2018, Prague, Czech Republic.
  • Wentzell N, Haug U, Schink T, Engel S, Liebentraut J, Linder R, Onken M, Schaefer C, Dathe K. Prescribing valproate to girls and women of childbearing age in Germany: Analysis of trends based on claims data. 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 22-26 August 2018, Prague, Czech Republic.
  • Knox CA, Mountford WK, Kaufman E, Mushnikov V, Mehtälä J, Wentzell N, Kollhorst B, Schink T, Korhonen P, Hoti F, Johansson G, Garbe E. Patterns of roflumilast use for the treatment of COPD across three distinct populations: Findings from the roflumilast PASS study. 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 25-28 August 2016, Dublin, Ireland.
  • Mushnikov V, Mehtälä J, Wentzell N, Kollhorst B, Schink T, Garbe E, Mountford WK, Knox CA, Kaufman E, Johansson G, Korhonen P, Hoti F. COPD patients initiating roflumilast in Sweden, Germany and the United States: Findings from the roflumilast PASS study. 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 25-28 August 2016, Dublin, Ireland.
  • Reinold J, Wentzell N, Schink T. Identification, adaptation and comparison of algorithms to estimate the beginning of pregnancy in the German Pharmacoepidemiological Research Database (GePaRD). Congress "Health - Exploring Complexity: An Interdisciplinary Systems Approach (HEC2016)." Joint Annual Meeting of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS), the German Society for Epidemiology (DGEpi), the International Epidemiological Association - European Region (IEA-EEF) and the European Federation for Medical Informatics Association (EFMI), 28 August-2 September 2016, Munich. (Abstract published in: European Journal of Epidemiology. 2016;31(Suppl.1):S162)
  • Wentzell N, Kollhorst B, Schink T. Predictors for the prescription of aclidinium bromide as compared to tiotropium bromide using German claims data. 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 25-28 August 2016, Dublin, Ireland.

For further publications please follow this link:

  • Social and Health Management at Institute for Further Training at University of Hamburg Public Health, 2015 - 2017
  • European Master of Science in Epidemiology at Johannes Gutenberg-University Mainz Secondary data for health research, WT 2016/2017, WT 2017/2018, WT 2019/2020

The responsibility for the content of this page lies with Nadine Wentzell.

Contact

Phone:
+49 (0)421 218-56-879
e-mail:
wentzell(at)leibniz-bips.de